Projected Price to Earnings: CytoSorbents Corporation (CTSO)
Military clashes are driving demand for blood purification in field hospitals, although sanctions complicate logistics. The forward P/E metric for Cytosorbents (CTSO) clearly confirms these trends, with the ratio currently reaching 0.00. Patent protection of the cytokine sorption niche, combined with high cartridge margins, creates powerful operating leverage for profit growth at Cytosorbents.
Metric breakdowns and analytics for CytoSorbents Corp. (CTSO)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Capital Cytosorbents|CTSO - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Cytosorbents|CTSO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio CytoSorbents Corp|CTSO - Company Long-Term Liabilities|Company Short-Term Debts Cytosorbents|Quick Ratio cytosorbents.com
- financial results and valuation multiples details:
CTSO - Company Profit|Projected Future Earnings Cytosorbents|CTSO - Business Payback Period|Forward P/E Multiple Cytosorbents|CTSO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple CytoSorbents Corp|CTSO - Operating profit EBITDA|Earnings per share for the last twelve months Cytosorbents|CTSO - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months cytosorbents.com|CTSO - Earnings per share increase in current year|Earnings growth forecast for next year Cytosorbents
Fundamental valuation:CTSO CytoSorbents Corporation
High margins in the production of sorption cartridges and the operating leverage effect from scaling within intensive care units create a foundation for the rapid profit growth of Cytosorbents (CTSO). The company's expected P/E ratio quantifies this potential by comparing market capitalization with projected earnings, allowing investors to assess the premium paid for future growth and determine the risk of correction through the price action of this chart.
Competitors of Cytosorbents
Forward P/E Multiple DXCM|PEN - Projected Price to Earnings Ratio|Novanta Corp - Projected Price to Earnings|Forward P/E Multiple Haemonetics Company HAE|INSP: Projected Price to Earnings|procept-biorobotics.com - Market Cap to Future Earnings Ratio|CNMD: Forward P/E Multiple|PLSE - Market Cap to Projected Earnings|INMD (InMode Corp) - Forward P/E Multiple|Projected Price to Earnings Picard Group (PMI)|Projected Price to Earnings SRDX (Surmodics, Inc.)|SENS (Senseonics Holdings, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings NeuroPace NPCE|TCMD - Projected Price to Earnings|SANUWAVE Health, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio Outset Medical Corp|ELMD: Forward P/E Multiple|Price to Future Earnings Ratio LNSR|RCEL (AVITA Medical) - Forward P/E Multiple|Profound Medical Corporation (PROF) - Market Cap to Projected Earnings|Forward P/E Multiple BDMD|Projected Price to Earnings edap-tms.com EDAP|Forward P/E Multiple APYX (Apyx Medical Corporation)|Forward P/E Multiple IceCure Medical Ltd. ICCM|LUNG - Future Price to Earnings|TELA: Future Price to Earnings|SRTS (Sensus Healthcare Corp) - Projected Price to Earnings|Zynex Corp - Future Price to Earnings Multiple|ECOR (electroCore Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio Vicarious Surgical Corp RBOT|Future Price to Earnings Inspira Technologies Oxy (IINN)|SeaStar Medical Holding Corporation (ICU) - Forward Price to Earnings Multiple|IRIDEX - Projected Price to Earnings|Forward P/E Multiple Intelligent Bio Solutions Inc INBS|AINostix - Forward P/E Multiple|Market Cap to Projected Earnings profusa.com PFSA|strataskinsciences.com (SSKN) - Future Price to Earnings|Price to Expected Earnings Ratio GCTK (glucotrack.com)|Future Price to Earnings NanoVibronix|Projected Price to Earnings Venus Concept Corporation (VERO)|Forward P/E Multiple NUWE|AEMD - Projected Price to Earnings Ratio|Future Price to Earnings Asensus Surgical ASXC|AVGR: Price to Future Earnings Ratio|BSGM: Projected Price to Earnings|Cutera Inc - Market Cap to Future Earnings Ratio|KNW: Forward P/E Multiple|Projected Price to Earnings inarimedical.com|Projected Price to Earnings NVRO|Projected Price to Earnings Ratio ReShape Lifesciences Inc RSLS|Projected Price to Earnings SILK (Silk Road Medical Inc.)
